Lung Diseases Clinical Trial
Official title:
Accuracy of Ultra-Low-Dose-CT (ULDCT) of the Chest Compared to Plain Film in an Unfiltered Emergency Department Patient Cohort
This trial compares the accuracy provided by plain film as well as ultra-low-dose-computed-tomography (ULDCT) of the chest. It also aims to analyze differences in diagnostic confidence and therapeutic consequence offered by these two imaging modalities.
For nearly a century, chest X-ray (plain film, projectional radiography) has been the
established primary imaging modality for patients with acute chest pain, suspected pneumonia,
and / or acute dyspnoea in the diagnostic pathway of emergency departments, although the
sensitivity and specificity of this X-ray technique are moderate.
The widespread availability and use of chest X-ray is due to the low acquisition and
operating costs for projectional radiography equipment, the short examination time, and the
very low radiation exposure. In addition, projectional radiography of the chest often serves
as a guide for further, more sensitive, diagnostical procedures. However, these advantages
are partially offset by the disadvantages inherent to projectional methods: anatomical
structures may superpose or mask pathological structures. As a result, some areas of the lung
may be obscured, and assessment may therefore be limited.
Whereas computed tomography was reserved for certain clinical questions over the last few
decades, and, in most cases, served as a second imaging approach after plain film
radiography, it has increasingly evolved as a primary imaging modality for several
indications (e.g., suspicion of pulmonary embolism, highly suspected aortic dissection). This
rise of computed tomography was due not only to its significant advantage of no
superposition, but also partly driven by the marked reduction in radiation dose needed
without sacrificing image quality. This was driven by the development of new detectors,
modulation of tube current and voltage, as well as iterative reconstruction techniques. As a
result, recent computed tomography scanners currently offer not only a more precise
visualization of differences in tissue-attenuation and the significant advantage of the
absence of artefacts due to superposition, but also allow for imaging with a considerably
reduced radiation dosage compared to older scanners. Therefore, computed tomography may now
be utilized as screening method in specific indications that carry an increased risk of
certain pathologies (e.g., in long-time smokers). The introduction of the latest generation
of computed tomography devices about three years ago allowed for an even further reduction in
dose by filtering out low-energy photons using a tin filter, which offers the possibility of
a reduction in radiation dose by another 50 % or more for established CT indications. For
specific indications (e.g., lung nodules in follow-up), the radiation dose may even be
reduced to a tenth or one-hundredth of a standard-dose CT (SDCT).
The current reference dose-length-product (DLP) in Germany for thoracic standard-dose CT
(SDCT) is ~350 mGycm (effective dose ~6 mSv) and, for thoracic low-dose-CT (LDCT / HR-CT),
~100 mGycm (effective dose ~1.7 mSv). However, the latest devices (third-generation
dual-energy CT) provide the opportunity to considerably reduce the reference dose of thoracic
low-dose CT. In the current literature, these scans are referred to as Ultra-Low-Dose-CT
(ULDCT) and are usually associated with a radiation dosage of 0.14 to 0.5 mSv. For this dose
range, no standardized reference values have been published as yet.
The limiting factors of ULDCT are quantum noise, loss of spatial resolution, and other image
artefacts. Therefore, careful selection of appropriate CT protocols and dosage is mandatory
in order to achieve sufficient image quality to answer the respective diagnostic question.
Several papers have been published on the subject of ULDCT, which are dedicated to the
comparison of ULDCT with LDCT and/or SDCT. These papers conclude that this technology may be
used with sufficient sensitivity and specificity for indications such as dyspnea, emphysema,
or lung nodules. Due to the potential to reduce the radiation dose to less than 1/30 of a
standard-dose CT while still providing acceptable image quality with the latest generation of
devices, ULDCT of the chest is emerging as an interesting alternative to conventional chest
X-ray.
To the best of the authors' knowledge, there are currently no studies comparing and
evaluating ultra-low-dose-CT as a primary imaging alternative to chest X-ray in emergency
department patients.
This study aims to compare ULDCT and plain film of the chest with regard to their accuracy in
an unfiltered patient cohort of an emergency department. For this purpose, the investigator's
ULDCT protocol will use the lowest possible dose at which image quality is diagnostically
sufficient (approximately 0.2 mSv effective dose). This corresponds to less than 1/30 of the
radiation dose of a standard-dose CT of the chest and to only about 2.5 times the dose of a
chest X-ray in two views. This dose is equal to less than a month of natural background
radiation in Austria and less than the radiation exposure on an intercontinental flight.
In addition to the accuracy of ULDCT of the chest compared to plain film of the chest, this
trial also aims to analyze the clinical relevance of both methods by assessing the respective
impact on final diagnosis, as well as possible changes in therapy.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05563701 -
Evaluation of the LVivo Image Quality Scoring (IQS)
|
||
Completed |
NCT04908397 -
Carnitine Consumption and Augmentation in Pulmonary Arterial Hypertension
|
Phase 1 | |
Terminated |
NCT03309358 -
A Study of the Safety and Tolerability of Inhaled SNSP113 in Healthy Subjects and Subjects With Stable Cystic Fibrosis
|
Phase 1 | |
Completed |
NCT03682354 -
ESPB Versus INB With PCIA in Video-assisted Thoracic Surgery
|
N/A | |
Enrolling by invitation |
NCT03683186 -
A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension
|
Phase 3 | |
Completed |
NCT03626519 -
Effects of Menthol on Dyspnoea in COPD Patients
|
N/A | |
Recruiting |
NCT06004440 -
Real World Registry for Use of the Ion Endoluminal System
|
||
Completed |
NCT04874948 -
Absorption, Elimination and Safety of 14C-labeled Radioactive BTZ-043, a New Compound in TB Treatment
|
Phase 1 | |
Completed |
NCT02926768 -
Phase I/II Study of CK-101 in NSCLC Patients and Other Advanced Solid Tumors
|
Phase 1 | |
Completed |
NCT01443845 -
Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Fixed Dose Combinations of Long-acting β2-agonist (LABA) and Inhaled Corticosteroid (ICS)
|
Phase 4 | |
Completed |
NCT00281216 -
Innate and Adaptive Immunity in Individuals Experiencing Chronic Obstructive Pulmonary Disease Exacerbations
|
N/A | |
Completed |
NCT00269256 -
Stress, Environment, and Genetics in Urban Children With Asthma
|
N/A | |
Terminated |
NCT00233207 -
IC14 Antibodies to Treat Individuals With Acute Lung Injury
|
Phase 2 | |
Recruiting |
NCT00129350 -
Assessment of Heart and Heart-Lung Transplant Patient Outcomes Following Pulmonary Rehabilitation
|
Phase 1 | |
Active, not recruiting |
NCT00115297 -
Montelukast for Early Life Wheezing
|
Phase 2/Phase 3 | |
Completed |
NCT00094276 -
Intervention for Improving Asthma Care for Minority Children in Head Start
|
N/A | |
Completed |
NCT00091767 -
Genetic Studies in Difficult to Treat Asthma: TENOR
|
N/A | |
Completed |
NCT00089752 -
Continuous Positive Airway Pressure to Improve Milder Obstructive Sleep Apnea
|
N/A | |
Completed |
NCT00069823 -
Study of Acid Reflux in Asthma
|
Phase 3 | |
Completed |
NCT00083798 -
Family Linkage Study of Obstructive Sleep Apnea (OSA) in Iceland
|
N/A |